{"name":"Nocion Therapeutics","slug":"nocion-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQb2hKOER6RXFnUmNtTjFhdE15aVI2UUkzNFg2N0hQMnFNMmpXd3pWc2pBcU1FdFE2RVJQZXhQN01CX1lYdHZ5OUI0SXNBRTJqWk9pM1B6Rk03M2JNOTA2N25NS0o0NXl2VWtidkg4YU5kX1RwV1FQZ05UYTZjc1BXbkJDWjhCRS1LM1dRSTl1LUdjbU1rcUl2Qkx3YjZDaE5uYnhZZ2gzMWFvTF9JbW5iS0xFYXZGaTZlV0llSUFiUGtjNURzSzE5V25uSnBPN1g2TGpkcFdR?oc=5","date":"2026-04-01","type":"pipeline","source":"businesswire.com","summary":"Nocion Therapeutics Strengthens Board of Directors with Appointment of Mark Iwicki - businesswire.com","headline":"Nocion Therapeutics Strengthens Board of Directors with Appointment of Mark Iwicki","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxPaXRELXRlVG9TNUMwN1ZMX3NsM2dzaGp1b0I5ZmtUaF9oWUQxWkZGMGN0cm1ZZ1AtR2U0LVNlOVB0X2xHTE9Ub29yWXU4Vm9TTmtLTHNocXpJOFk3QnJQRDNrcmxGcE11TURRZE54RS02RjZRX3FNOXA3cDVHWjBDY09GdHhJMzh2MEtVMTdzSlZQQWZfUDhSUS14UHZZTWZWRHVvRHdMa2tsc1J0S1E5QTJTQ01IT0VwYTFjalVVcVAtaVVrVFZYVklSVVVucFVIU3BieGw5ajZ3WTFPekNoemlqVFdlUE9LcE1Pa0R4b0tYdzFvMzhmZWF2LVVPYmRvbWJLd3RQM1BHblZjYkRRRG8zMHJvZms?oc=5","date":"2025-11-24","type":"pipeline","source":"GlobeNewswire","summary":"Chronic Refractory Cough Market is Expected to Boom by 2034 - GlobeNewswire","headline":"Chronic Refractory Cough Market is Expected to Boom by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNWW1LOEJlbk5TT3ZQdmladTV5a1ZPbk9GeU5GRVRiYlpXUHpzZkRST3BWR093ZUtQNGc3TjlDOWUwQmVSc0hlSUJFdDdFLVRXa3UxNC1yd2UwaFJYalhJc1gtaDZGTjBiZDhZSGFzYWQwQWNjWEVhXzBYYnpuRVhUb3hRREJNdkpzamlsM09GRQ?oc=5","date":"2025-05-02","type":"pipeline","source":"fiercebiotech.com","summary":"Chutes & Ladders—Scholar Rock rocks the boat with new execs - fiercebiotech.com","headline":"Chutes & Ladders—Scholar Rock rocks the boat with new execs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQWUFGejF4UW1vM1l5OElYeTlRbHZfU2dhMnh1Sm9FOXlka094U0xOcE1lNGtUc01mTU12Sm5Xc1BDVDJCT0JKWHFUQUhZZWJEVWp4cDlJNXFQdmRtTGIza3d6OUc1b0J5UjBBUEh6Q3MwaGJ3anh4S2REcThZcjdmRG5rcndaZ1pUWDB1MVoxcEpQRWE1d0JKNkZ2UnFUUUpSRjdjQVVtSXBteWg0ZXlxdmhKVTBVVEZz?oc=5","date":"2025-04-28","type":"pipeline","source":"BioSpace","summary":"Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer - BioSpace","headline":"Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOT0RrUUFtbDBlUnNFZ3VaMnFBQTBzT3JIY0dHbmFodTUxVThFdEJCLVZ0WC1iNkNWUE9CRXo3QjZDQ2JYZ3d0NDM1N2NYRVVReFFSR09adjJScXNQQnVxWWgxMUZoVmNOQUxfeTJLSjNCLXZFcjJLWkFwdFhYQWx5WnNyRVFkZjRyMW9RbmNaZDFCWnVFYk1CR0laakRldVBxZnc?oc=5","date":"2024-03-05","type":"pipeline","source":"The Pharma Letter","summary":"With chronic cough ambitions, investors believe in Nocion - The Pharma Letter","headline":"With chronic cough ambitions, investors believe in Nocion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQeVFNbXRrWDhQVnJfOEZPdlNzT0RnWWRsRTJzdmhuR0NmYmFBUjNYLTExcnFWaXF4QllMUTcyR0ZGOWxJQVlrMjh6LXJONGp0RDZrTFBOTVEzZ2ZzUl93Y3ktQ3FoOUZHa25mZThlRHN3emxHbzZ1SHJvZ2JJMm41U2t4Tld6aXFoWndHM0lVZ29zZjlOU08wcFZPUkVHQQ?oc=5","date":"2024-03-04","type":"pipeline","source":"BioPharma Dive","summary":"Nocion, chasing GSK, pulls in $62M for chronic cough drug - BioPharma Dive","headline":"Nocion, chasing GSK, pulls in $62M for chronic cough drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNZXp1Um1nMHVDQy0tTDlxbXJTN0NPRk9UUEdCLXpBdENoVjFocWFDeGctZTgzUk9iem9DWlduSXVwNUlvVmZETWo3VUc5dm9ZdjFHcXpHMzl5blhaQWpkbzUwejlkUDg2UllIM2NLaFZmZkkyRlBfSmFVVlRUVzAyR3hPeHBialdlbm4yVGRpdlFyNDMtQU9JWmpncm45SUpBUDZ4OGdlWER5SlRkVHpXU2JUUU1NTk1CUWR3LXR2Z0VlUkk1U1F0STFLUkFvV3BHdjZoYkhxeWJjRXN1dk15cWpjT2dpUXhpQWlYRWdwUXp0M2dWZEdTanNLOERUQWM5WXp2X3JyQTg2dHdyeXc?oc=5","date":"2024-03-04","type":"pipeline","source":"businesswire.com","summary":"Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development - businesswire.com","headline":"Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Developme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPUDIzdWM2VDdGNmMyRGF6ZEwyMzhxOFlWbGZncl9VNEhXeVNZLUZrU3FwODlYeXp2Ukc0cGctZ1EtTm9TdmZpcVlGcTlKQmVfNHBDRjM2eW5YeUxxWkR3UHpYWlYxbmJveTlqd2hybUVhR2FBNjVNNkpPUHM5emhqWA?oc=5","date":"2019-09-23","type":"pipeline","source":"fiercebiotech.com","summary":"FierceBiotech's 2019 Fierce 15 - fiercebiotech.com","headline":"FierceBiotech's 2019 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPbGZ5RklIWnJRLTJmTzZqYVlxSExxN2NhakJvelhkMmQ4Q2xPWjVmMVpaS2J5US1MV2JCY0xXbS1PQ0IwUlJ5dDQ3VEQ2Y2tGMjFNdi1yakg5MFdXTGVQMHVMY2hmaVRoTDV0WlhhMWdaVUk1N2J0eDRLV01fTkhpcmlxYnczRXlKMWRCSzVKTy1KdWY0djUtUEZzRWk2WEkxeUt3M0hn?oc=5","date":"2019-04-17","type":"pipeline","source":"Business Insider","summary":"A startup just raised $27 million to make a new kind of painkiller using technology from Harvard scientists, as the race to replace opioids heats up - Business Insider","headline":"A startup just raised $27 million to make a new kind of painkiller using technology from Harvard scientists, as the race","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}